Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: A case report

被引：8

作者：

Yamada K. ^{[1
]}

Asai K. ^{[1
]}

Okamoto A. ^{[1
]}

Watanabe T. ^{[1
]}

Kanazawa H. ^{[1
]}

Ohata M. ^{[2
]}

Ohsawa M. ^{[2
]}

Hirata K. ^{[1
]}

机构：

[1] Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, 1-4-3, Asahi-machi, Abeno-ku, Osaka

[2] Diagnostic Pathology, Graduate School of Medicine, Osaka City University, 1-4-3, Asahi-machi, Abeno-ku, Osaka

来源：

BMC Research Notes | / 11卷 / 1期

基金：

日本学术振兴会;

关键词：

CADM; Clinically amyopathic dermatomyositis; Corticosteroids; Cyclophosphamide; MDA5; Melanoma Differentiation-Associated gene 5; Rapidly progressive interstitial lung disease; RP-ILD; Tacrolimus;

D O I：

10.1186/s13104-018-3146-7

中图分类号：

学科分类号：

摘要：

Background: Clinically amyopathic dermatomyositis with anti-Melanoma Differentiation-Associated gene 5 (MDA5) antibody often presents with severe interstitial lung disease. Although serum ferritin level is known to reflect interstitial lung disease activity, there are few case reports describing this association. Case presentation: A 58-year-old man was referred to our outpatient clinic with a 3-week history of cough and respiratory distress. He had erythema over the V area of the neck and a Gottron's sign. Chest computed tomography revealed diffuse ground-glass opacities and reticular shadows in both lungs. Test for anti-MDA5 antibody was positive. After admission, he received triple combination therapy (methylprednisolone pulse therapy, tacrolimus, and cyclophosphamide). However, his respiratory condition worsened as the serum ferritin level increased. Despite no apparent deterioration on chest radiography, he ultimately died due to respiratory failure. Conclusions: In this case, triple combination therapy was not effective for the patient's respiratory condition. The serum ferritin level was correlated with disease activity and was more useful than chest radiography for monitoring clinical status. © 2018 The Author(s).

引用

共 15 条

[1]

Mukae H., Ishimoto H., Sakamoto N., Hara S., Kakugawa T., Nakayama S., Ishimatsu Y., Kawakami A., Eguchi K., Kohno S., Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis, Chest, 136, 5, pp. 1341-1347, (2009)

[2]

Ikeda S., Arita M., Misaki K., Mishima S., Takaiwa T., Nishiyama A., Ito A., Furuta K., Yokoyama T., Tokioka F., Et al., Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: A retrospective cohort study, Springerplus, 4, (2015)

[3]

Kotani T., Makino S., Takeuchi T., Kagitani M., Shoda T., Hata A., Tabushi Y., Hanafusa T., Early intervention with corticosteroids and cyclosporin A and 2-h post dose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis, J Rheumatol, 35, 2, pp. 254-259, (2008)

[4]

Nagata K., Tomii K., Nanjo S., Kubota M., Tachikawa R., Nishio M., Four cases of interstitial pneumonia associated with amyopathic dermatomyositis characterized by the anti-CADM-140 antibody, Nihon Kokyuki Gakkai Zasshi, 49, 1, pp. 30-36, (2011)

[5]

Gono T., Kawaguchi Y., Hara M., Masuda I., Katsumata Y., Shinozaki M., Ota Y., Ozeki E., Yamanaka H., Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis, Rheumatology (Oxford), 49, 7, pp. 1354-1360, (2010)

[6]

Tazelaar H.D., Viggiano R.W., Pickersgill J., Colby T.V., Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings, Am Rev Respir Dis, 141, 3, pp. 727-733, (1990)

[7]

Rosenschein U., Radnay J., Shoham D., Shainberg A., Klajman A., Rozenszajn L.A., Human muscle-derived, tissue specific, myocytotoxic T cell lines in dermatomyositis, Clin Exp Immunol, 67, 2, pp. 309-318, (1987)

[8]

Goebels N., Michaelis D., Engelhardt M., Huber S., Bender A., Pongratz D., Johnson M.A., Wekerle H., Tschopp J., Jenne D., Et al., Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis, J Clin Invest, 97, 12, pp. 2905-2910, (1996)

[9]

Dumont F.J., FK506, an immunosuppressant targeting calcineurin function, Curr Med Chem, 7, 7, pp. 731-748, (2000)

[10]

Webster A., Woodroffe R.C., Taylor R.S., Chapman J.R., Craig J.C., Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients, Cochrane Database Syst Rev, 4, (2005)

← 1 2 →